<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Christian Bleiholder - Florida State University News</title>
	<atom:link href="https://news.fsu.edu/tag/christian-bleiholder/feed/" rel="self" type="application/rss+xml" />
	<link>https://news.fsu.edu/tag/christian-bleiholder/</link>
	<description>The Official News Source of Florida State University</description>
	<lastBuildDate>Thu, 30 Jan 2025 20:14:45 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.4</generator>
	<item>
		<title>FSU chemists advance biotherapeutics with innovative imaging research</title>
		<link>https://news.fsu.edu/news/science-technology/2025/01/30/fsu-chemists-advance-biotherapeutics-with-innovative-imaging-research/</link>
		
		<dc:creator><![CDATA[Bill Wellock]]></dc:creator>
		<pubDate>Thu, 30 Jan 2025 20:14:45 +0000</pubDate>
				<category><![CDATA[Science & Technology]]></category>
		<category><![CDATA[Christian Bleiholder]]></category>
		<category><![CDATA[College of Arts and Sciences]]></category>
		<category><![CDATA[Department of Chemistry and Biochemistry]]></category>
		<category><![CDATA[Faculty]]></category>
		<guid isPermaLink="false">https://news.fsu.edu/?p=101325</guid>

					<description><![CDATA[<img src="https://news.fsu.edu/wp-content/uploads/2025/01/Researchers-1.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="From left, Florida State University faculty researcher Fanny C. Liu and Christian Bleiholder, a professor in the Department of Chemistry and Biochemistry. Their work on the protein dynamics in the NIST monoclonal antibody was published in Chemical Communications. (Bill Wellock/University Communications)" style="float: left; margin-right: 5px;" link_thumbnail="" decoding="async" fetchpriority="high" srcset="https://news.fsu.edu/wp-content/uploads/2025/01/Researchers-1.jpg 900w, https://news.fsu.edu/wp-content/uploads/2025/01/Researchers-1-512x341.jpg 512w, https://news.fsu.edu/wp-content/uploads/2025/01/Researchers-1-768x512.jpg 768w" sizes="(max-width: 900px) 100vw, 900px" /><p>Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments for diseases such [&#8230;]</p>
<p>The post <a href="https://news.fsu.edu/news/science-technology/2025/01/30/fsu-chemists-advance-biotherapeutics-with-innovative-imaging-research/">FSU chemists advance biotherapeutics with innovative imaging research</a> appeared first on <a href="https://news.fsu.edu">Florida State University News</a>.</p>
]]></description>
										<content:encoded><![CDATA[<img src="https://news.fsu.edu/wp-content/uploads/2025/01/Researchers-1.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="From left, Florida State University faculty researcher Fanny C. Liu and Christian Bleiholder, a professor in the Department of Chemistry and Biochemistry. Their work on the protein dynamics in the NIST monoclonal antibody was published in Chemical Communications. (Bill Wellock/University Communications)" style="float: left; margin-right: 5px;" link_thumbnail="" decoding="async" srcset="https://news.fsu.edu/wp-content/uploads/2025/01/Researchers-1.jpg 900w, https://news.fsu.edu/wp-content/uploads/2025/01/Researchers-1-512x341.jpg 512w, https://news.fsu.edu/wp-content/uploads/2025/01/Researchers-1-768x512.jpg 768w" sizes="(max-width: 900px) 100vw, 900px" /><p>Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments for diseases such as cancer, Alzheimer&#8217;s disease, autoimmune disorders and infectious diseases.</p>
<p>New research from the Florida State University Department of Chemistry and Biochemistry shows that a particular type of monoclonal antibody known as NISTmAb retains its structure even if the sugar molecules attached to it are changed. The work, which was published in <a href="https://pubs.rsc.org/en/content/articlelanding/2024/cc/d4cc02125h">Chemical Communications</a>, is a pivotal step in understanding protein dynamics in NISTmAb and offering clarity to biopharmaceutical developers who use monoclonal antibodies to develop new treatments.</p>
<p>“Understanding how sugar molecules influence how monoclonal antibodies behave has been a long-standing challenge in biotherapeutics,” said Associate Professor Christian Bleiholder, who led the research. “Modifying the sugar parts of the antibody doesn’t seem to affect its overall structure or how it behaves, which is important when developing antibodies as a treatment.”</p>
<p>Monoclonal antibodies are the largest group of biologic drugs, which are made from living organisms and come in many forms. These molecules need to maintain a specific structure to function properly, as any significant changes in their shape can disrupt their ability to bind to a target.</p>
<figure id="attachment_101332" aria-describedby="caption-attachment-101332" style="width: 600px" class="wp-caption aligncenter"><img decoding="async" class="wp-image-101332 size-full" src="https://news.fsu.edu/wp-content/uploads/2025/01/Diagram.gif" alt="A diagram showing results from the Tandem-TIMS instrument. The x-axis shows the cross section, or the size of the ions. The y-axis represents the abundance of ions with that particular cross section. The black line shows the results for the NIST monoclonal antibody. An illustration of the NIST monoclonal antibody appears to the right. (Courtesy of Fanny Liu)" width="600" height="600" /><figcaption id="caption-attachment-101332" class="wp-caption-text">A diagram showing results from the Tandem-TIMS instrument. The x-axis shows the cross section, or the size of the ions. The y-axis represents the abundance of ions with that particular cross section. The black line shows the results for the NIST monoclonal antibody. An illustration of the NIST monoclonal antibody appears to the right. (Courtesy of Fanny Liu)</figcaption></figure>
<p>To study the mAb structure, Bleiholder worked with Melvin A. Park at Bruker Daltonics, to develop a groundbreaking technique called tandem-trapped ion mobility spectrometry, or Tandem-TIMS. The technique allowed scientists to study proteins and other molecules in a way that helps preserve their structure so researchers could study how their shape changes under different conditions.</p>
<p>This patented technology has been a decade in the making. Bleiholder learned how to perform ion mobility mass spectrometry as a postdoctoral researcher at the University of California, Santa Barbara, where he observed a molecular change during the onset of Alzheimer’s disease. When he started his laboratory in 2013 at Florida State University, he began the process of developing the new measurement technique. The result was a breakthrough that allowed scientists to investigate the structure and stability of complex proteins like NISTmAb in unprecedented detail.</p>
<p>“It was rewarding to see that after working for over 10 years on making this method we were finally able to apply it to solve problems,” Bleiholder said.</p>
<p>The study used Tandem-TIMS to isolate and analyze subpopulations of the NIST monoclonal antibody, a standard antibody in biotherapeutic research. Bleiholder’s team confirmed that structural variations among antibody populations are not influenced by glycosylation — a process in which sugar molecules attach to other molecules. The research marks a pivotal step in understanding protein dynamics and offering clarity to biopharmaceutical developers.</p>
<p>“Our study sheds new light on the relationship between the various structures of antibodies and their properties after protein translation,” said FSU faculty researcher Fanny C. Liu, who was the paper’s lead author. “This work opens exciting possibilities for accelerating the engineering of new biotherapeutic treatments for patients.”</p>
<p>The research will make it easier to design monoclonal antibodies by looking into how sugar molecules attached to them affect their shape and stability. This breakthrough could accelerate drug development timelines and enhance the quality of biotherapeutics, benefiting patients worldwide.</p>
<p>The research has sparked collaborations with industry leaders such as Johnson &amp; Johnson to explore applications of this technology in enhancing biomedical development.</p>
<p>Bleiholder’s lab is expanding the applications of Tandem-TIMS to include the structural analysis of other proteins critical to biomedical research, including the SARS-CoV-2 spike protein and HIV capsid assembly. The lab is also pioneering methods for imaging proteins in tissue samples, paving the way for advances in personalized medicine.</p>
<p>FSU co-authors on this research were Jusung Lee and Thais Pedrete. Collaborators from Bruker Daltonics were Erin M. Panczyk and Stuart Pengelley. This work was supported by the National Science Foundation and the National Institutes of Health.</p>
<p>The post <a href="https://news.fsu.edu/news/science-technology/2025/01/30/fsu-chemists-advance-biotherapeutics-with-innovative-imaging-research/">FSU chemists advance biotherapeutics with innovative imaging research</a> appeared first on <a href="https://news.fsu.edu">Florida State University News</a>.</p>
]]></content:encoded>
					
		
		
			<enclosure url="http://news.fsu.edu/wp-content/uploads/2025/01/Researchers-1.jpg" length="354095" type="image/jpeg"/>
		</item>
		<item>
		<title>FSU program helps faculty bring research to market</title>
		<link>https://news.fsu.edu/news/science-technology/2023/06/02/fsu-program-helps-faculty-bring-research-to-market/</link>
		
		<dc:creator><![CDATA[Bill Wellock]]></dc:creator>
		<pubDate>Fri, 02 Jun 2023 13:39:49 +0000</pubDate>
				<category><![CDATA[Science & Technology]]></category>
		<category><![CDATA[Anne Spencer Daves College of Education Health and Human Sciences]]></category>
		<category><![CDATA[Christian Bleiholder]]></category>
		<category><![CDATA[College of Arts and Sciences]]></category>
		<category><![CDATA[Department of Chemistry and Biochemistry]]></category>
		<category><![CDATA[Department of Nutrition and Integrative Physiology]]></category>
		<category><![CDATA[Faculty]]></category>
		<category><![CDATA[GAP competition]]></category>
		<category><![CDATA[Office of Research]]></category>
		<category><![CDATA[Prashant Singh]]></category>
		<guid isPermaLink="false">https://news.fsu.edu/?p=85669</guid>

					<description><![CDATA[<img src="https://news.fsu.edu/wp-content/uploads/2022/04/2021_OR_Research-generic-9x6-02.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="float: left; margin-right: 5px;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://news.fsu.edu/wp-content/uploads/2022/04/2021_OR_Research-generic-9x6-02.jpg 900w, https://news.fsu.edu/wp-content/uploads/2022/04/2021_OR_Research-generic-9x6-02-512x341.jpg 512w, https://news.fsu.edu/wp-content/uploads/2022/04/2021_OR_Research-generic-9x6-02-768x512.jpg 768w" sizes="(max-width: 900px) 100vw, 900px" /><p>Research to improve the detection of Salmonella and to speed up the development of new medicines received funding from a [&#8230;]</p>
<p>The post <a href="https://news.fsu.edu/news/science-technology/2023/06/02/fsu-program-helps-faculty-bring-research-to-market/">FSU program helps faculty bring research to market</a> appeared first on <a href="https://news.fsu.edu">Florida State University News</a>.</p>
]]></description>
										<content:encoded><![CDATA[<img src="https://news.fsu.edu/wp-content/uploads/2022/04/2021_OR_Research-generic-9x6-02.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="float: left; margin-right: 5px;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://news.fsu.edu/wp-content/uploads/2022/04/2021_OR_Research-generic-9x6-02.jpg 900w, https://news.fsu.edu/wp-content/uploads/2022/04/2021_OR_Research-generic-9x6-02-512x341.jpg 512w, https://news.fsu.edu/wp-content/uploads/2022/04/2021_OR_Research-generic-9x6-02-768x512.jpg 768w" sizes="(max-width: 900px) 100vw, 900px" /><p>Research to improve the detection of <em>Salmonella</em> and to speed up the development of new medicines received funding from a Florida State University program that supports faculty moving their work from the lab to the marketplace.</p>
<p>FSU’s Office of the Vice President for Research awarded faculty members $70,000 through the Spring 2023 GAP Commercialization Investment Program.</p>
<p>“Translating technology from talented FSU faculty is an important part of our mission,” said Vice President for Research Stacey Patterson. “Programs like GAP help mature these often-nascent ideas and get them out to the world where they can have positive impact.”</p>
<p>Funded proposals were:</p>
<p><strong>A more precise system for detecting <em>Salmonella</em> in food:<br />
</strong><em>Salmonella</em> is a leading cause of food poisoning worldwide, causing 93 million infections every year. Current testing methods for <em>Salmonella</em> don’t distinguish between samples with a single cell of the bacteria and millions of cells. Prashant Singh, an assistant professor in the Department of Nutrition and Integrative Physiology in the College of Health and Human Sciences, developed a test to analyze the concentration of the bacteria in samples, not just the presence. His test can tell users if the contamination level in a sample is zero, low, medium or high. Agencies that regulate food in the United States are considering adopting testing methods that can quantify how much <em>Salmonella</em> exists in poultry samples, which would provide a broader market for Singh’s test. GAP funding will help him improve the latest version of his testing method.</p>
<p><strong>A process to speed up the discovery of new drugs:<br />
</strong>Developing new drugs typically costs more than a billion dollars and can take more than a decade. Among the challenges are identifying a target on which a drug can act and optimizing different candidate medicines. Analytical chemistry methods can screen interactions between a target and libraries of small molecules to help create new drugs. Christian Bleiholder, an associate professor in the Department of Chemistry and Biochemistry in the College of Arts and Sciences, developed software to improve the drug candidate selection and optimization process. He will use GAP funding to improve his software’s computational efficiency, integrate it with cloud-based computing services and make it more user-friendly, with the goal of creating a software product that is ready for use in industry.</p>
<p>For more information about the GAP competition, visit the <a href="https://www.research.fsu.edu/research-offices/oc/">FSU Office of Commercialization</a>.</p>
<p>The post <a href="https://news.fsu.edu/news/science-technology/2023/06/02/fsu-program-helps-faculty-bring-research-to-market/">FSU program helps faculty bring research to market</a> appeared first on <a href="https://news.fsu.edu">Florida State University News</a>.</p>
]]></content:encoded>
					
		
		
			<enclosure url="http://news.fsu.edu/wp-content/uploads/2022/04/2021_OR_Research-generic-9x6-02.jpg" length="341161" type="image/jpeg"/>
		</item>
	</channel>
</rss>
